Risk of contraceptive failure with anaesthesia drug ‘seldom disclosed’
UK researchers say sugammadex interacts with progesterone and can reduce the effectiveness of hormonal contraceptives
Women of child-bearing age are seldom informed about the risk of contraceptive failure following exposure to the common anaesthesia drug sugammadex, new UK research suggests.
According to a survey of anaesthetists across University College London Hospitals (UCLH) NHS Foundation Trust sites, almost all said they were aware of this risk yet only 30% discussed it with patients.
